Levbid News

ISSUE: Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) to the consumer level which include the tablet, sublingual, and orally disintegrating tablet form. This recall is being initiated due to both superpotent and subpotent test results. All of these batches were manufactured by Pharmatech LLC for distribution by Virtus throughout the United States and Puerto Rico. See the press release for a listing of affected batch numbers. Taking a product that is superpotent could result in hot/dry skin, fever, blurred vision, sensitivity to light, dry mouth, unusual excitement, fast or irregular heartbeat, dizziness, an inability to completely empty the bladder, and seizures. The severity of the adverse event would depend on how superpotent the tablet was. Adverse events such as clotted blood within the tissues and fractures could ... Read more

TUESDAY, March 3, 2015 – Drugs used to treat a wide range of health problems may be associated with an increased risk of pneumonia, a new study suggests. Anticholinergic medications include those used for conditions such as allergies (for example, Benadryl), overactive bladder (including Ditropan), depression (for example, doxepin) and insomnia (Sominex, etc.). "Our study is the first to address whether oral anticholinergic medications affect the risk of pneumonia in older people," senior author Dr. Sascha Dublin, an associate investigator at the Seattle-based Group Health Research Institute, said in an institute news release. "This is important because so many older people use these medications, and pneumonia is such a common cause of illness and death in this age group," Dublin explained. Researchers looked at more than 1,000 patients with pneumonia, aged 65 to 94, and a group of ... Read more